AstraZeneca
rare disease highlights innovative delivery platforms expanding genomic research furthering our genomic capabilities acquisitions and collaborations complement existing technologies and increases genomic medicine portfolio | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
July 2023
Slide
27 of 44
Related slides by other companies
Dare Bioscience
Investor Presentation
February 2023
intravaginal ring technology highlights the vaginal route of drug administration our technology design features vaginal drug delivery offers many potential advantages due to large surface area dense network of blood vessels and high elasticity due to presence of smooth muscle fibers recognized advantages include comparable ease of administration and ability to bypass hepatic first pass metabolism sustained drug delivery variable dosing and duration solid ethylene vinyl acetate polymer matrix that can contain and release one or several active drugs no need for membrane or reservoir to contain active drug or control the release | Dare Bioscience
Missfresh
Investor Day
September 2021
innovative and experienced management team with a firm belief in technology tiger | Missfresh
AngloAmerican
Results
February 2023
innovative technologies in development roll out | AngloAmerican
Genetron
Results
May 2021
mutation capsule our innovative and proprietary technology | Genetron
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io